TAG
GLP
39 articles
Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often
health
Women with PMOS should get subsidised weight loss drugs, advocates say
world
Why you need to take a closer look at your favorite stock index
finance
We’re still figuring out the side effects of GLP-1 weight-loss drugs
jurnal
Have We Been Overstating GLP-1 Muscle Loss?
health
GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution
finance
Yes, You Can Maintain Muscle on a GLP-1. This Plan Shows You How.
health
Gut mRNA tech supercharges vaccine and GLP-1 delivery
health
Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
finance
‘Astonishing’ weight loss when GLP-1 drug used with second medication
science
Most powerful obesity drug yet: People lost up to 25% of weight in trial
tech
GLP-1 Users Face Stigma From Friends and Family, Study Finds
politics
Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.
finance
Activating nucleus tractus solitarius neurons that project to the nucleus accumbens attenuates cocaine seeking via enhanced GLP-1 signaling in the ventral striatum of rats
science
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
tech
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
health
Dozens of people sue GLP-1 drug companies over alleged vision loss
world
Should we use GLP-1 drugs to treat obesity in children?
science
Stopping Ozempic may raise heart attack and stroke risk
science
Ozempic can change your body. Can it change your life?
science
From ‘Ozempic breath’ to hair loss: sorting the science from the hype about weight loss jabs
health
‘I’m sick of her talking about it’: 11 readers share how GLP-1s have affected their relationships
health
Americans’ demand for ‘protein-maxxing’ isn’t slowing down as GLP-1s sweep country
world
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
science
Mind over metabolism: a systematic review of GLP-1 receptor agonists in the treatment of stress-related disorders
science
Could GLP-1 Drugs Help Us Live Longer? New Study Shows Promise
politics
GLP-1 use in kids under-12 soars - even without FDA approval
world
Is GLP-1 Stock Amylyx Still a Buy After Skyrocketing 247%?
finance
Victoria's Secret stock soars nearly 300% as GLP-1 weight-loss drugs help reshape lingerie buying habits
finance
Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify
health
GLP-1 maker hit with 'sell' rating as 2027 revenue cliff fears mount
finance
How GLP-1 Sales Could Play Out for Hims & Hers
finance
Will muscle-boosting meds be the next big thing after GLP-1 drugs?
science
New daily diabetes pill that helps with weight loss launches in UK pharmacies
world
Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify
health
Big Food Stocks Suffer From GLP-1 Indigestion. Find Bargains in PepsiCo and Smucker.
finance
Can weight-loss drugs lose their nasty side effects?
finance
US man posed as doctor in fraudulent scheme to profit from Ozempic, prosecutors say
world
‘A tax on being thin’: only high earners make overall savings on food bills from weight-loss drugs
world
Related tags
Some
Can
Müharibə
Ongoing
Retatrutide
FDA
Mercedes
Americans
Children
Dozens
Süni intellekt
People